Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
| NCT number |
NCT06227299 |
| Other study ID # |
INTEGRAL |
| Secondary ID |
|
| Status |
Enrolling by invitation |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
May 29, 2018 |
| Est. completion date |
January 2030 |
Study information
| Verified date |
January 2024 |
| Source |
Swiss Glaucoma Research Foundation |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
The aim of this study is to create a large-scale register of all glaucoma patients diagnosed,
followed and treated in a large tertiary centre specialising in glaucoma, in order to analyse
whether specific factors influence the progression of the disease or guide our choice of
treatment. This should lead to a better understanding of the disease and the factors to be
taken into account when choosing the best treatment option for each patient, leading to
safer, more effective and patient-centred care.
Description:
Glaucoma encompasses a group of chronic diseases characterized by progressive retinal nerve
fibre loss and a concomitant pattern of visual field damage, eventually leading to blindness.
To date, it is still considered the first cause of irreversible blindness worldwide. In
recent years, treatment options for glaucoma have soared, and ophthalmologists can resort to
a wide selection of drops, laser procedures and surgical techniques to reduce intraocular
pressure, and slow the progression of the disease. The choice of the technique, however,
often depends on personal preferences and it is still unclear if a specific technique is more
efficient or safe, or if any patient-depending factors should guide the choice of treatment.
The aim of this study is to create a large-scale register of all glaucomatous patients
diagnosed, followed-up and treated in a large glaucoma-specialised tertiary centre, to
analyse if any specific factor influence the progression of the disease or guide our
treatment choice. This should lead to a better understanding of the disease itself and of the
factors that should be considered when choosing the best treatment option for each patient,
leading to safer, more efficient and more patient-centered care. This registry is thus of
great importance for both patients and clinicians in the diagnosis and treatment of glaucoma.
The study is an observational analysis of patients' medical data recorded in a large-scale
register, both retrospective and prospective.
